Use of a novel fluorescent glucose sensor in volunteer subjects with type 1 diabetes mellitus

Journal of Diabetes Science and Technology

Volumn 5, Issue 3, 2011, Pages 687-693

  Peyser, Thomas ^a   Zisser, Howard ^b   Khan, Uzma ^b   Jovanovič, Lois ^b   Bevier, Wendy ^b   Romey, Matt ^c   Suri, Jeff ^c   Strasma, Paul ^c   Tiaden, Stephanie ^c   Gamsey, Soya ^c  

^a DexCom Inc   (United States)

^b GluMetrics Inc   (United States)

^c SANSUM DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

Accuracy; Fluorescence; Hypoglycemia; Intravascular continuous glucose monitor; Sensor; Tight glycemic control

Indexed keywords

GLUCOSE;

ADOLESCENT; ADULT; ARTICLE; ARTIFACT; BLOOD GLUCOSE MONITORING; CHILD; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENT GLUCOSE SENSOR; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT SAFETY; PRESCHOOL CHILD; RELIABILITY; SCHOOL CHILD; AGED; ALGORITHM; BLOOD; CALIBRATION; EQUIPMENT DESIGN; METHODOLOGY; MIDDLE AGED; PILOT STUDY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SELF CARE; SPECTROFLUOROMETRY; TIME;

ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SELF CARE; SPECTROMETRY, FLUORESCENCE; TIME FACTORS;

EID: 84858765953     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500323     Document Type: Article

References (10)

1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107-24. (Pubitemid 32163181)
2. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63(2):356-61. (Pubitemid 27084552)
3. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-21. (Pubitemid 36644877)
4. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-67.
5. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
6. Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94(9):3163-70.
7. Krinsley JS. Glycemic variability in critical illness and the end of Chapter 1. Crit Care Med. 2010;38(4):1206-8.
8. Mebis L, Gunst J, Langouche L, Vanhorebeek I, Van den Berghe G. Indication and practical use of intensive insulin therapy in the critically ill. Curr Opin Crit Care. 2007;13(4):392-8. (Pubitemid 47015774)
9. Gamsey S, Suri JT, Wessling RA, Singaram B. Continuous glucose detection using boronic acid-substituted viologens in fluorescent hydrogels: linker effects and extension to fiber optics. Langmuir. 2006;22(21):9067-74. (Pubitemid 44626176)
10. Bridges BC, Preissig CM, Maher KO, Rigby MR. Continuous glucose monitors prove highly accurate in critically ill children. Crit Care. 2010;14(5):R176.